 |
 |
Not only the often longer manuscript review periods, but also the time it takes to conduct (i.e., establish/generate financial and human resources, recruit participants, collect and analyze data, etc.) ID research, certainly notably determine their impact relative to research conducted in other, even related fields. Levels of interest in the general topic from other, related fields (e.g., neuroscience for autism) also notably affect impact relative Impact Factors within the ID field, in that those other, often faster moving, fields then sometimes cite relevant articles. Finally, the purpose/aims of research and the scientists who conduct the research, as well as their target audience (e.g., other researchers who will cite the work versus practicioners who will not likely or frequently cite the work), affects citation impact, which is what Impact Factors are solely based upon. Thus, longer manuscript review periods are an issue, and potentially a factor that can be changed more than some of hte others. But, perhaps review times are not the key or critical issue. See also: http://blogs.biomedcentral.com/bmcblog/2013/06/21/impact-more-about-the-research-and-less-about-the-factor/